By Duncan Bridgeman
Friday 28th November 2003
|Text too small?|
At noon yesterday Tower shares had tumbled another 6c, or 4.7% to $1.23, following a 4.5% drop on Wednesday when the insurer reported a worse than expected $149 million annual loss.
The result, mainly due to writeoffs from changes in accounting policy, was softened by news the troubled transtasman group had traded back into profitability, with a $5.5 million net profit for the second half.
Tower's problem area continues to be in Australia, where the division lost $13.1 million for the year and $6.6 million in the six months to September 30.
However, despite expecting more one-off costs, Tower Australia was budgeting for a financial profit this year, chairman Olaf O'Duill said.
Mr O'Duill said the improved second half reflected more favourable investment conditions and the reduced impact of one-off items including writedowns in carrying values.
Group managing director Keith Taylor said yesterday Tower Australia was making steady progress but continued to experience significant costs in repositioning the division in respect of compliance issues.
"We overpaid some people more than we underpaid in terms of withdrawal benefits," he said.
He said the company had included a provision of about $4.5 million that covered both compensation and remedial actions.
Tower, 17.7% owned by Guinness Peat Group and 9.7% by Hanover Group, has culled much of its senior management after nine months of a two-year recovery mission.
The company has also sold a business and bolstered its balance sheet through a $210 million rights issue, the proceeds of which were used to repay debt and reduce the company's gearing from 45% to 22%.
No comments yet
Heartland Market Update
Steel & Tube Fy20 Trading Update
Further Contract Win Strengthens Scott Technology’s Position In Mining Sector
China’s Assertiveness Is Becoming a Problem for Its Friends, Too
New Talisman - Chairman’s Address to AGM 2020 August 6, 2020
T&G reports its 2020 Interim Results
Gold price hits $2,000 for first time on Covid
TruScreen strengthens its market presence in central and eastern Europe
Refining NZ announces non-cash impairment
Ryman Healthcare COVID-19 update Victoria